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INTERMITTENT AORTIC 
CROSSCLAMPING 
PREVENTS CUMULATIVE 
ADENOSINE TRIPHOSPHATE 
DEPLETION, VENTRICULAR 
FIBRILLATION, AND 
DYSFUNCTION (STUNNING): 
IS IT PRECONDITIONING? 
This study was designed to determine whether intermittent warm aortic 
crossclamping induces cumulative myocardial stunning or if the myocar- 
dium becomes preconditioned after the first episode of ischemia in canine 
models in vivo. The role of adenosine triphosphate catabolism and subse- 
quent release of purines on reperfusion-mediated postischemic ventricular 
dysfunction and arrhythmias was assessed with the use of selective 
inhibitors of nucleoside transport, p-nitrobenzylthioinosine (NBMPR), and 
a specific adenosine deaminase inhibitor, erythro-9-[2-hydroxy-3-nonyl] 
adenine (EHNA). Thirty-two anesthetized ogs were instrumented to 
monitor left ventricular contractility, off bypass, by sonomicrometry. Dur- 
ing cardiopulmonary b pass dogs were treated before ischemia with either 
saline solution (control group, n = 8) or EHNA (100 pmol/L) and NBMPR 
(25/~mol/L) (EHNA/NBMPR group, n = 8). Hearts were subjected to either 
60 minutes of global ischemia nd 120 minutes of reperfusion (n = 16) or 
6 episodes of 10 minutes of global ischemia nd 10 minutes of reperfusion, 
followed by 60 minutes of reperfusion ( = 16). Sixty minutes of sustained 
ischemia resulted in 80% loss of adenosine triphosphate and induced 
reperfusion-mediated ventricular fibrillation and severe left ventricular 
dysfunction in the control group. EHNA/NBMPR treatment augmented 
myocardial adenosine trapping during ischemia, attenuated ventricular 
fibrillation, and enhanced left ventricular functional recovery, despite 
similar depletion of adenosine triphosphate (80% loss). In the intermittent 
ischemia experiment, he first episode of 10 minutes of ischemia and 
reperfusion caused significant adenosine triphosphate depletion, ventricu- 
lar fibrillation, and left ventricular stunning in both control and drug- 
treated groups. The prevalence of ventricular fibrillation was greater in the 
control group than in the drug-treated group after the first episode of 
ischemia (p < 0.05). Adenosine was the major nucleoside accumulated in
the myocardium at the end of 10 minutes of ischemia in the EHNA/ 
NBMPR-treated group (p < 0.05 versus control). Subsequent episodes of 
ischemia prevented ventricular fibrillation and did not cause cumulative 
left ventricular stunning in either group. Left ventricular function 
fully recovered in the EHNA/NBMPR-treated group after intermittent 
ischemia, but remained stunned in the control group. Unlike sustained 
ischemia, intermittent ischemia and reperfusion preserved myocardial 
adenosine triphosphate, limited purine release, and prevented ventricular 
fibrillation and cumulative stunning. These results suggest that intermit- 
tent ischemia and reperfusion augmented the endogenous protective 
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mechanism or mechanisms of "preconditioning." Nucleoside trapping improved 
functional recovery after sustained or repetitive ischemia. It is concluded that 
adenosine triphosphate preservation or blockade of nucleoside transport may play 
an important role in the activation of endogenous myocardial protective mecha- 
nisms that "precondition" against subsequent ischemic stress. (J TnORAC CARDIO- 
VASC SURG 1995;110:328-39) 
A lthough hypothermic ardioplegic arrest has been the procedure of choice for myocardial 
protection during coronary artery bypass grafting, 
some surgeons continue to use an old technique of 
intermittent noncardioptegic warm aortic cross- 
clamping with satisfactory results, and interest in 
this technique has been renewed. Mechanisms un- 
derlying myocardial injury during warm intermittent 
global ischemia nd reperfusion are not known. 1-3 
Recently, intermittent warm cardioplegic arrest has 
been used as a mean of myocardial protection 
during elective cardiac operation. 1 
A brief coronary artery occlusion provokes deple- 
tion of adenosine triphosphate (ATP), reperfusion- 
mediated ventricular fibrillation, and persistent 
ventricular dysfunction referred to as myocardial 
stunning.4-8 On the other hand, repetitive brief cor- 
onary artery occlusion and reperfusion have been 
shown to significantly reduce the rate of ATP de- 
pletion and concomitant accumulation of ATP 
catabolites 9, lo and to limit the infarct size after a 
sublethal period of sustained ischemia nd reperfu- 
sion. ~1 A single episode of 5 minutes of coronary 
artery occlusion produced a similar antiinfarction 
response. ~2 These observations suggested that the 
myocardium becomes more tolerant o ischemia by 
activating an adaptive response to short periods of 
ischemic stress. The reduction of the infarct size 
after brief ischemia and reperfusion followed by 
prolonged ischemia nd reperfusion has been re- 
ferred to as ischemic preconditioning. 1~'12 It is not 
known whether a brief episode of ischemia and 
reperfusion also limits ventricular dysfunction after 
intermittent ischemia nd reperfusion in a canine 
model of warm aortic crossclamping. 
The mechanisms ofmyocardial stunning and isch- 
emic preconditioning have not been fully elucidated 
because of age-, species-, and model-related differ- 
ences. 13 Oxygen-derived free radicals 8'14 and im- 
pairment of contractile apparatus and handling of 
calcium by sarcoplasmic reticulum ~s have been im- 
plicated in myocardial stunning. Preservation of 
myocardial ATP, 11 activation of A 1 receptors, 12and 
ATP-sensitive potassium channels a6 and induction 
of heat-shock proteins 17 are among potential mech- 
anisms of cardioprotection associated with ischemic 
preconditioning. Pharmacologic trapping of endog- 
enous adenosine by a selective nucleoside transport 
blocker, p-nitrobenzylthioinosine (NBMPR), and a 
specific adenosine deaminase inhibitor, erythro-9- 
[hydroxy-3-nonyl]adenine (EHNA), has been shown 
to attenuate ventricular dysfunction after 30 and 60 
minutes of ischemia in dogs 18-21 without a prior 
ischemic preconditioning episode. It is not known 
whether entrapment of endogenous adenine nucle- 
oside augments ventricular functional recovery and 
attenuates ventricular arrhythmias during intermit- 
tent aortic crossclamping and reperfusion. 
In the clinical setting, myocardial stunning and 
ischemic preconditioning may occur during re- 
peated angina, angioplasty, or thrombolysis. 22-24 
Whether the phenomena of myocardial stunning 
and preconditioning occur during cardiac operation 
with noncardioplegic warm intermittent aortic cross- 
clamping is not known. The role of ATP depletion 
and nucleoside accumulation and release during 
intermittent ischemia nd reperfusion was investi- 
gated in the present studies. 
Material and methods 
The following study protocols conform with the guid- 
ing principles of the American Physiological Society. 
All animals were treated humanely inaccordance with the 
United States Public Health Service Standards a  outlined 
in "Principles of Laboratory Animal Care" formulated by 
the National Society of Medical Research and the "Guide 
for the Care and Use of Laboratory Animals" prepared by 
the National Academy of Sciences and published by the 
National Institutes of Health. 
Material. Biochemical reagents were obtained from 
Sigma Chemical Company (St. Louis, Mo.). NBMPR was 
obtained from Aldrich Chemical Company (Milwaukee, 
Wis.); EHNA was purchased from Sigma Chemical Com- 
paw. 
Animal preparation. Thirty-two microfilaria-free dogs 
of either sex, weighing 19 to 26 kg, were anesthetized with 
intravenous injections of sodium pentobarbital (Nembu- 
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tal, 30 mg/kg, Abbott Laboratories, Chicago, Ill.). Dogs 
were intubated and the lungs mechanically ventilated with 
a Bennett MA1 respirator (Puritan, Berkeley, Calif.). The 
azygos vein was ligated and the right phrenic nerve was 
transected to eliminate diaphragmatic contractions. The 
sinoatrial node was crushed, and the heart was paced 
at 150 beats/rain with a Medtronie 5880A pacemaker 
(Medtronic, Inc., Minneapolis, Minn.). Porcine-based 
heparin (400 units/kg, given intravenously) was injected 
before bypass followed by 200 units/kg per hour (Elkins- 
Sinn Inc., Cherry Hill, N.J.). Cardiopulmonary b pass was 
initiated by subclavian artery cannulation for blood inflow 
and right atrial cannulation with use of a double-stage 
cannula for venous drainage. A bubble oxygenator (Cobe 
CML50, 100, Cobe, Lakewood, Colo.) primed with non- 
crossmatched homologous blood was used. Arterial blood 
gas values, pH, hematocrit, and electrolyte levels were 
determined before and during bypass. Mean arterial 
perfusion pressure was maintained at 65 mm Hg during 
cardiopulmonary b pass. 
Assessment of left ventricular performance and reper- 
fusion-mediated arrhythmias. Intraventricular and ca- 
rotid artery micromanometer-tipped catheters (Millar In- 
struments, Inc., Houston, Tex.) were used to monitor left 
ventricular and systemic pressure, respectively. LV dimen- 
sions were obtained with pulse transit sonomicrometry 
(Triton Technology, San Diego, Calif.). One pair of 
2.5 mm diameter LTZ-piezoelectric hemispheric rystals 
(Channel Industries, Santa Barbara, Calif.) was sewn onto 
the anterior and posterior myocardial wall along the 
minor axis of the left ventricle. The epicardial diameter of 
the left ventricle ranged from 40 to 66 ram. Analog data 
were digitized at 200 Hz and stored on the hard disk of a 
PC 386 microcomputer. Subsequent analysis was done 
with the use of interactive software Crunch program 
developed in our laboratory. To assess left ventricular 
performance, the dog was first temporarily weaned from 
bypass. Then the left ventricular and arterial pressures 
were elevated to 100 to 120 mm Hg by crossclamping the 
venous drainage and increasing the blood inflow through 
the subclavian eannula by the roller pump. The relation- 
ship of stroke work/end-diastolic length was established 
over a range of end-diastolic volumes produced by emp- 
tying venous blood into the cardiopulmonary b pass res- 
ervoir during 25 to 50 beats (10 to 20 seconds). Cardio- 
pulmonary bypass was then reestablished. During data 
collection, all hemodynamic parameters changed, corre- 
sponding to the left ventriclar emptying maneuver, except 
the heart rate, which was kept constant by electric pacing 
(150 beats/rain). Work loops were produced on a screen 
and recorded, and the relationship between stroke work 
and end-diastolic length was calculated using Crunch 
program analysis. The slope of this linear relationship is 
the most sensitive index of contractility, independent of 
the load within the physiologic rangeY' 26 Assessment of 
left ventricular function by this method is more accurate 
than hemodynamic and load-dependent indices of con- 
tractility such as left ventricular arterial pressure and 
positive and negative values of the rate of left ventricular 
pressure rise. The latter parameters decreased as the work 
loop diminished uring data collection because of varying 
preload. The numbers of occurrences of ventricular fibril- 
lation and successful resuscitation were recorded and the 
frequency of reperfusion-mediated ventricular tachycar- 
dia was determined uring lO-minute periods of intermit- 
tent or sustained reperfusion. 
Assessment of adenine nucleotide pool intermediate 
metabolism. In a random fashion, transmural Tru-Cut 
needle (Travenol Laboratories, Inc., Deerfield, Ill.) biopsy 
specimens (5 to 10 rag) were obtained during 60 min- 
utes of intermittent normothermic global ischemia and 
60 minutes of sustained reperfusion. Biopsy samples 
were immediately frozen and stored in liquid nitrogen. 
Purines in each biopsy specimen were extracted with 12% 
trichloroacetic acid (4°C) and neutralized. Denatured 
protein content from each biopsy specimen was deter- 
mined as previously described by Lowry. 27 Levels of 
myocardial ATP, adenosine diphosphate (ADP), adeno- 
sine monophosphate (AMP), adenosine, inosine, hypo- 
xanthine, xanthine, and the oxidized form of nicotin- 
amide-adenine dinucleotide were determined with 
high-performance liquid chromatography and ex- 
pressed as nanomoles per milligram protein. 28" 29 
Experimental protocol. Dogs underwent either 60 min- 
utes of sustained myocardial ischemia nd 120 minutes of 
rcperfusion or six episodes of 10 minutes of normothermic 
global myocardial ischemia nd 10 minutes of reperfusion, 
followed by 60 minutes of continuous perfusion during 
cardiopulmonary b pass. All hearts underwent 60 minutes 
of global warm ischemia nd 120 minutes of reperfusion. 
To determine the role of purine release on ventricular 
dysfunction, arrhythmias, and adenine nucleotide pool 
metabolism, a selective nucleoside transport blocker, 
NBMPR, and an adenosine deaminasc inhibitor, EHNA, 
were infused into the bypass reservoir before ischemia. 
One bolus (500 ml) of either saline solution (in the control 
group) or a solution of EHNA (100/xmol/L) and NBMPR 
(25 txmol/L) (in the EHNA/NBMPR-trcated group) was 
infused into the pump reservoir before ischemia. The 
effects of the vehicle or drugs on left ventricular contrac- 
tility and the levels of myocardial adenine nucleotide and 
nucleoside metabolism were determined in normal hearts 
before ischemia. A second bolus (500 ml) was infused 
immediately before sustained ischemia or before the first 
episode of ischemia. A third bolus (500 ml) was infused at 
the beginning of 60 minutes of sustained reperfusion to 
ensure availability of effective inhibitor concentrations. 
Transmural biopsy specimens were obtained before 
ischemia, at the end of each episode of ischemia and 
reperfusion, and during sustained reperfusion. Left ven- 
tricular performance was assessed, after the dog was 
weaned from bypass, from the slope of the relationship 
between stroke work and end-diastolic length. Postisch- 
emic reperfusion-mediated ventricular arrhythmias were 
documented after each ischemic episode. 
Statistical analysis. Data are presented as mean plus 
or minus the standard error of the mean. Sequential 
measurements were compared with repeated-measures 
analysis of variance (ANOVA) with SAS software (Statis- 
tical Analysis System Institute, Cary, N.C.). Subsequent 
comparisons were made between groups at each individ- 
ual period of the experiment by the method of Newman 
and Keuls. Differences were considered significant if the 
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Fig. 1. Effect of sustained global ischemia on ATP metabolism and ventricular performance with and 
without nucleoside trapping. Effect of sustained warm ischemia (60 minutes) on ATP, adenosine inosine 
levels, and ventricular performance in presence and absence of EHNA/NBMPR. A, Effect of sustained 
ischemia on ATP. Levels of ATP were determined before, during, and after 60 minutes of ischemia (37 ° C). 
There were statistically significant differences between groups (p < 0.05, ANOVA, n = 8 each group). 
Significant differences between groups at each point are represented by asterisks. B, Effect of sustained 
ischemia on adenosine. Adenosine levels were determined before, during, and after 60 minutes of ischemia 
(37 ° C). There were statistically significant differences between groups (p < 0.05, ANOVA, n = 8 each 
group). Significant differences between groups at each point are represented by asterisks. C, Effect of 
sustained ischemia on inosine. Inosine levels were determined before, during, and after 60 minutes of 
ischemia (37 ° C). There were statistically significant differences between groups (p < 0.05, ANOVA, n = 
8 each group). Significant differences between groups at each point are represented by asterisks. D, Effect 
of sustained ischemia on left ventricular performance. Left ventricular performance was determined before 
and after vehicle of EHNA/NBMPR administration to determine the effect of drugs on normal myocardial 
function. There were no significant differences between groups before ischemia. Significant recovery of 
ventricular function after 60 minutes of sustained ischemia was observed in EHNA/NBMPR-treated group, 
whereas recovery was severely impaired in control group (p < 0.05, ANOVA, n = 8 each group). 
significant differences between groups at each point are represented by asterisks. CPBP, Cardiopulmonary 
bypass; G × T, group and time; SW/EDL, stroke work/end-diastolic length. 
probability value (p) for comparison of best least-squares 
means was less than 0.05. 
Results 
Sustained ischemia. Sixty minutes of sustained 
ischemia caused severe depletion of myocardial 
ATP  (about  80% loss) (Fig. 1,A) and concomitant  
accumulat ion of nucleosides (Fig. 1, B and C) in 
the control  ,and EHNA/NBMPR- t reated  groups. 
F requency of reper fus ion-mediated  ventr icular  fi- 
br i l lat ion was greater  (100%) in the control  group 
than in the drug-t reated group (68%) after 60 
minutes of sustained ischemia (p < 0.05). Left  
ventr icular  funct ion was complete ly  recovered in 
the EHNA/NBMPR- t reated  group, whereas  poor  
recovery of funct ion (23% of basel ine value) was 
observed in the control  group (Fig. 1, D)  (p < 
0.05). 
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Fig. 2. Effect of intermittent ischemia on ATP with and without nucleoside trapping. Effect of intermittent 
global normothermic ischemia nd reperfusion on myocardial ATP in presence and absence of EHNA/ 
NBMPR is depicted. There were no significant differences between groups with respect to ATP levels as 
demonstrated byANOVA (p = NS, n = 8 each group). However, at one point only there was significant 
increase in ATP between groups, as represented byasterisk. 
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Fig. 3. Effect of intermittent ischemia on ventricular performance with and without nucleoside trapping. 
Effect of intermittent global normothermic schemia and reperfusion on left ventricular function in 
presence and absence of EHNA/NBMPR is depicted. There were significant differences between groups 
after reperfusion (p < 0.05, ANOVA, n = 8 each group). Significant differences between groups at each 
point are represented byasterisks. 
Intermittent ischemia. Fig. 2 depicts the effect of 
intermittent normothermic global ischemia and 
reperfusion on ATP depletion and left ventricular 
performance. Administration of EHNA/NBMPR 
did not alter physiologic levels of adenine nucleo- 
tides (ATP, ADP, AMP), nucleosides (adenosine, 
inosine), or oxypurines (hypoxanthine, xanthine) 
before ischemia. The first 10 minutes of normother- 
mic global ischemia resulted in slight depletion of 
myocardial ATP from 24.67 _+ 2.0 to 20.59 _+ 1.8 
nmol/mg protein in the control group (16.54% re- 
duction) and from 25.16 + 2.5 to 21.73 + 1.4 
nmol/mg protein in the drug-treated group (13.63% 
reduction) (Fig. 3). Myocardial ATP levels de- 
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Table I. Effect of intermittent ischemia nd 
reperfusion on myocardial adenosine 
Adenosine (nmol/mg protein) 
Time Control* EHNA/NBMPR* 
Preischemia 0 0.15 _+ 0.12 
Vehicle or drug 0.16 _+ 0.08 0.10 _+ 0.12 
First ischemia 0.38 ___ 0.04? 5.23 _+ 0.68t$ 
First repeffusion 0.02 ± 0.01t 2.80 _+ 0.27t$ 
Second ischemia 0 4.84 ± 1.177~ 
Second reperfusion 0.01 ± 0.01 0.59 ± 0.1075 
Third ischemia 0.29 ± 0,01? 1.96 + 0.1775 
Third reperfilsion 0.05 _+ 0,04 1.79 _+ 0.75?$ 
Fourth ischemia 0.21 _+ 0.01t 2.18 _+ 1.00t$ 
Fourth reperfusion 0.08 _+ 0,04t 1,14 ± 0.66t$ 
Fifth ischemia 0.53 ± 0,10? 0.70 -+ 0.19t:~ 
Fifth reperfusion 0.11 ± 0,03t 0.63 _+ 0.30t~ 
Sixth ischemia 0.10 - 0.06 2.08 ± 0.60t~ 
Sixth reperfusion 0.05 + 0.04 0.22 -4- 0.18t 
90 min reperfusion 0.14 ± 0.10 0.27 -+ 0.10t 
120 min reperfusion 0 0.26 _+ 0.10t 
*p < 0.05 between groups with repeated-measures ANOVA, n = 8 each 
group. 
tp < 0.05 versus preischemia. 
Sp < 0.05 versus the control group. 
creased to 15.86 + 1.2 nmol/mg protein (35.7% reduc- 
tion) in the control group and to 15.78 _+ 0.6 nmol/mg 
protein (37.28% reduction) in the EHNA/NBMPR 
group after flhe second episode of ischemia (p < 0.05 
versus preisclhemia). No significant recovery of myo- 
cardial ATP values was observed within 10 minutes of 
reperfusion in either group, except after the third 
reperfusion period. Statistical analysis revealed that 
both groups behaved similarly with respect to the time 
of the experiment (p --- NS,* ANOVA). No further 
decline in myocardial ATP values was noted in either 
group after the third episode of ischemia nd reperfu- 
sion or after 60 minutes of sustained reperfusion. A 
slight increase in myocardial ATP values was observed 
at the end of 60 minutes of rcperfusion in the drug- 
treated group. 
A transient increase in levels of myocardial ADP 
and AMP was observed after the first episode of 
ischemia, and these levels decreased during the first 
episode of reperfusion (p = NS between groups). 
Total adenine nucleotide levels followed the pattern 
of ATP depletion. The adenine nucleotide pool 
declined rapidly after the first episode of ischemia 
and then stabilized without further loss after the 
third episode of ischemia nd reperfusion. 
Administration of EHNA/NBMPR did not ele- 
vate the leve, ls of adenosine or inosine in normal 
*NS = Not significant. 
Table II. Effect of intermittent ischemia nd 
reperfusion on myocardial inosine 
Inosine (nmol/mg protein) 
Time Control* EHNA/NBMPR* 
Preischemia 0 0.29 + 0.19 
Vehicle or drug 0 0 
First ischemia 1.60 _+ 0.20? 0.36 -+ 0.30:~ 
First reperfusion 0 0 
Second ischemia 0.22 _+ 0.19t 1.03 _+ 0.60t:~ 
Second repeffusion 0 0.14 _+ 0.08:~ 
Third ischemia 0.33 ± 0.14t 0.12 + 0.065 
Third reperfusion 0 0 
Fourth ischemia 0.09 ± 0.08t 0.44 _+ 0.02~ 
Fourth reperfusion 0 0.05 _+ 0.04 
Fifth ischemia 0.53 ± 0.107 0.46 ± 0,36 
Fifth repeffusion 0 0 
Sixth ischemia 0.8 ± 0.06 0.55 _+ 0.405 
Sixth reperfusion 0 0.19 ± 0,17t 
90 min reperfusion 0.09 -+ 0.07 0.07 _+ 0,04? 
120 rain reperfusion 0 0 
*p < 0.05 between groups with repeated-measures ANOVA, n = 8 each 
group. 
tp < 0.05 versus preischemia. 
~p < 0.05 versus the control group. 
myocardium before ischemia (Tables I and II). In 
the intermittent ischemia experiments, adenosine 
levels increased uring 10 minutes of warm ischemia 
in the EHNA/NBMPR group from 0 to 5.23 + 0.68 
nmol/mg protein. Adenosine levels were signifi- 
cantly lower in the control group (0.31 _+ 0.1 
nmol/mg protein) than those in the drug-treated 
group (p < 0.05). After the first episode of reperfu- 
sion, adenosine was not detectable in the control 
group, whereas ignificant levels of adenosine (2.8 + 
0.27 nmol/mg protein) were detected in the drug- 
treated group. At the end of the first 10 minutes of 
ischemia, inosine accumulated in the untreated con- 
trol group (1.60 _+ 0.2 nmol/mg protein) (p < 0.05 
versus preischemia) nd washed out during reperfu- 
sion (Table II). Inosine levels were 1.03 _+ 0.6 
nmol/mg protein in the drug-treated group at the 
end of the second episode of ischemia. During the 
second and third episodes of ischemia, accumulation 
of inosine and adenosine decreased in the control 
and EHNA/NBMPR groups, respectively. There 
was no further production of inosine in the control 
group after the second episode of ischemia. On the 
other hand, diminishing levels of adenosine were 
noted in the drug-treated group with subsequent 
ischemic and reperfusion episodes. 
Before ischemia, myocardial hypoxanthine and 
xanthine were undetectable. However, a transient 
rise in myocardial hypoxanthine and xanthine levels 
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was observed in both groups during the first episode 
of ischemia and these washed out during reperfu- 
sion. The levels of oxypurines, generated uring 
ischemia, compared with the amounts of adenosine 
and inosine, were negligible. There was no signifi- 
cant loss of myocardial oxidized nicotinamide-ade- 
nine dinucleotide observed uring warm intermit- 
tent global ischemia and reperfusion as compared 
with preischemic levels. 
In the control group, 10 minutes of ischemia 
resulted in significant ventricular dysfunction (myo- 
cardial stunning) in both groups (Fig. 3). The slope 
of stroke work/end-diastolic ength recovered only 
to 65% of normal in both groups (p < 0.05 versus 
preischemia). Subsequent episodes of ischemia nd 
reperfusion did not cause cumulative ventricular 
dysfunction in the control group or in the drug- 
treated group. During sustained reperfusion after 
six episodes of ischemia and reperfusion, left ven- 
tricular function was not improved or worsened in 
the control group after the first episode of ischemia. 
Administration of EHNA/NBMPR did not change 
the slope of stroke work/end-diastolic length in 
normal hearts before ischemia. Five subsequent 
episodes of ischemia and reperfusion also did not 
cause additional stunning over that induced by the 
first ischemic episode in the drug-treated group. 
There were no significant differences between 
groups, after each episode of intermittent ischemia 
and reperfusion, with respect o global ventricular 
function (p -- NS). However, a marked recovery of 
left ventricular performance (95.1 _+ 11.8 dynes/cm 2 
× 103) was observed in the EHNA/NBMPR-treated 
group during sustained reperfusion (p < 0.05 versus 
control group, p = NS versus preischemia). Full 
recovery of left ventricular function was observed at 
30 and 60 minutes of sustained reperfusion in the 
drug-treated group (p < 0.05 versus control group, 
p = NS versus preischemic function). 
The prevalence of reperfusion-mediated v ntric- 
ular fibrillation observed after the first episode of 
ischemia was more pronounced in the control group 
than in the drug-treated group. In the control group, 
seven out of eight dogs had reperfusion-mediated 
ventricular fibrillation (87.4%), whereas three out of 
eight dog hearts fibrillated in the drug-treated group 
(37.4%) (p < 0.05). Frequency of ventricular tachy- 
cardia was also greater (51%) in the control group 
than in the EHNA/NBMPR-treated group (13%) 
(p < 0.05). Ventricular arrhythmias did not recur 
during subsequent episodes of ischemia nd reper- 
fusion in either group. 
Discussion 
The rationale of the present study was to deter- 
mine whether intermittent warm aortic crosselamp- 
ing induces cumulative myocardial stunning or 
whether the myocardium becomes preconditioned 
after the first episode of ischemia. To achieve this 
goal, left ventricular performance was correlated 
with the myocardial level of adenine nucleotides 
pool intermediates before and after intermittent or 
sustained myocardial ischemia nd reperfusion in a 
dog model in vivo. The role of ATP catabolism and 
subsequent release of purines on reperfusion-medi- 
ated postischemic ventricular dysfunction and ar- 
rhythmias was assessed with the use of selective 
inhibitors of nucleoside transport (NBMPR) and 
adenosine deaminase (EHNA). 
In the present studies, 60 minutes of sustained 
warm ischemia and reperfusion resulted in severe 
loss of ATP (80%), reperfusion-mediated v ntricu- 
lar fibrillation, and severe ventricular dysfunction i  
the untreated control animals. In the EHNA/ 
NBMPR-treated group, a marked recovery of ven- 
tricular function was observed despite significant 
depletion of ATP (80%) and concomitant accumu- 
lation of adenosine. In the intermittent ischemia 
model, the first episode of brief ischemia resulted in 
ATP depletion, ventricular fibrillation, and ventric- 
ular dysfunction (stunning) in both the control and 
drug-treated groups. Five additional episodes of 
ischemia did not cause cumulative ATP depletion, 
ventricular fibrillation, or stunning. 
This is an important observation because of its 
clinical ramifications. In the clinical setting of car- 
diac operation, warm intermittent aortic cross- 
clamping was used for coronary artery bypass graft- 
ing before the introduction of hypothermia nd 
cardioptegia. This technique is still being used by a 
limited number of surgeons with satisfactory mor- 
bidity and mortality results. Patients undergoing 
intermittent warm aortic crossclamping may have 
myocardial stunning after the first ischemic episode 
and, in the meantime, this may induce an adaptive 
response to the first episode of oxidative stress 
similar to that seen in the present study. 
Nucleoside trapping by EHNA/NBMPR im- 
proved ventricular functional recovery during sus- 
tained reperfusion periods in models of both sus- 
tained and intermittent ischemia. Left ventricular 
function remained epressed (stunned) to the same 
degree as that induced by the first episode of 
ischemia after 60 minutes of reperfusion in the 
control group. These results suggest that the 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 2 
Abd-Elfattah, Ding, Wechsler 3 3 5 
stunned heart is able to recover within 30 minutes of 
sustained reperfusion when pretreated with EHNA/ 
NBMPR. Because functional recovery was mea- 
sured at 30-minute intervals during reperfusion after 
60 minutes of sustained ischemia, it is not known 
whether left ventricular function was fully recovered 
after 10 minutes of reperfusion. Previous studies 
demonstrated that pharmacologic intervention with 
EHNA/NBMPR before or after ischemia selectively 
targets postischemic reperfusion i jury without atten- 
uating metabolic derangement during ischemia. 18-21 
Although all animals in the present studies were 
subjected to 60 minutes of cumulative ischemic 
time, the pathophysiologic processes in the two 
experimental protocols might not necessarily be 
comparable. However, it is interesting to note that 
significant attenuation of cumulative ventricular 
dysfunction and arrhythmias occurred uring inter- 
mittent aortic crossclamping in the presence or 
absence of inhibitors of nucleoside transport and 
adenosine deaminase. The mechanisms by which the 
heart can tolerate intermittent ischemia nd reper- 
fusion, after the first ischemic episode, are not 
known. However, it is well established that myocar- 
dial injury sustained by the heart during postisch- 
emic reperfusion is directly related to the duration 
of ischemia nd myocardial salvage on reperfusion. 
Therefore the element of reperfusion may explain 
the lack of cumulative ATP derangement and vcn- 
tricular dysfunction in the present study. Another 
possible explanation is that the first ischemic epi- 
sode could have preconditioned the myocardium 
against additional episodes of ischemia and reper- 
fusion in a manner similar to that previously de- 
scribed by lintiting the infarct size. 12' 16, 17 It is plausible 
that the "memory" of prior oxidative stress induced 
certain biochemical changes that made the heart more 
tolerant to five additional episodes of ischemia. Murry, 
Jennings, and Reimer 11 showed that the rate of ATP 
depletion was significantly reduced during repetitive 
coronary artery occlusion and markedly limited the 
size of infarction when these hearts were further 
subjected to a sublethal episode of sustained coronary 
occlusion in dogs. In the latter study, ventricular 
function was not measured. It has been reported that 
activation of A~ receptor, protein kinase C and KAT P 
channels, and induction of heat shock proteins may 
play a role in reducing the size of myocardial infarc- 
tion. 3°-33 It is interesting to note that these interven- 
tions are also known to reduce the rate of ATP 
depletion during prolonged ischemia. Warner and 
associates 34hypothesized that preconditioned myocar- 
dium produces fewer hydrogen ions during sustained 
ischemia, thus protecting the heart against further 
injury. 
Results from the present studies demonstrate hat 
the ATP pool is better preserved in the model of 
intermittent ischemia and reperfusion than in the 
model of sustained ischemia. The latter adaptive 
response is known to be species independent. 
Whether this adaptive response to the first episode 
of ischemia in this model of intermittent global 
ischemia nd reperfusion, that is, lack of cumulative 
ventricular stunning, could be referred to as a form 
of preconditioning, is debatable. Nucleoside trap- 
ping, during 30 minutes of a sustained ischemic 
period in dogs, resulted in complete recovery of 
ventricular function and repletion of ATP. is These 
results further support previous observations that 
the release of ATP catabolites, but not ATP levels, 
plays a crucial role in the phenomena of postisch- 
emic ventricular dysfunction "stunning" and vcntric- 
ular arrhythmias. ~s' 20 Van der Heide, Reimer, and 
Jennings 3s reported that intracoronary infusion of 
adenosine or an adenosine receptor agonist reduces 
the rate of ATP depletion during lethal episodes of 
ischemia. 
Free radicals have been implicated in myocardial 
stunning after coronary artery occlusion in the ab- 
sence of myocardial necrosis. 14' 19, 36, 37 Previous 
work from this laboratory demonstrated that site- 
specific blockade of nucleoside transport only at the 
time of reperfusion attenuated global myocardial 
stunning in the absence of adenosine. 2~' 36, 38 These 
results also suggest that free radical generation 
via the ATP catabolism pathway plays a role in 
myocardial stunning. Zuoghaib and associates 37
demonstrated that intracoronary infusion of EHNA/ 
NBMPR augmented adenosine levels during isch- 
emia and attenuated ventricular dysfunction inde- 
pendent of coronary collateral and hemodynamic 
changes. Changes in the sensitivity of myofilaments 
to calcium may also contribute to contractile dys- 
function. 39 It is not known whether calcium-medi- 
ated ventricular dysfunction is a secondary event o 
free radical-mediated membrane injury. 
Whether myocardial stunning is a prerequisite for 
ischemic preconditioning in the present study may 
be surmised by the lower recovery (71% of baseline 
values) of preconditioned myocardium in the un- 
treated control group compared with 23% recovery 
after 60 minutes of sustained ischemia. Therefore 
the greater ecovery of cardiac function after inter- 
mittent ischemia and reperfusion in the untreated 
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control group may reflect an adaptive response to 
the first short episode of ischemia. Although these 
results support previous reports that precondition- 
ing does not attenuate myocardial stunning, 4°'4a 
lack of cumulative ventricular dysfunction in the 
present study may be partially explained by an 
ischemic preconditioning phenomenon. Although 
several pieces of evidence have accumulated that 
argue against he notion that myocardial stunning 
induces the phenomenon of ischemic precondition- 
ing, the relationship between stunning and precon- 
ditioning remains controversial. 42-46 The argument 
is based on the following observations: (1) myocar- 
dial stunning persists for hours, whereas the precon- 
ditioning protective ffect lasts 1 hour or 24 hours; 
(2) heat shock, Al-receptor agonists, and KAT P 
channel openers limit the infarct size, thus mimick- 
ing ischemic preconditioning, without he need for a 
brief ischemic episode 36' 37; and (3) inotropic stim- 
ulation by catecholamine increases ventricular con- 
tractitity of the stunned myocardium. 45The latter 
observations may imply that myocardial stunning is 
not a prerequisite for ischemic preconditioning. 46 A 
temporary increase in contractility of the stunned 
heart induced by infusion of catecholamine, 45 
cAMP, or calcium may reflect an adequate contrac- 
tile reserve of the stunned heart but not necessarily 
abolish stunning. The heart eventually returns to its 
stunned state after catecholamine withdrawal. 
Therefore, by definition, ischemic preconditioning 
requires a period of ischemia, whereas heat shock, 
A 1 agonist, and KAa- P channel openers may induce 
intrinsic mechanisms of protection similar to those 
of preconditioning but not mediated by ischemia. 
Most of these interventions are believed to preserve 
ATP during sustained ischemia. 
It has been reported that brief episodes (2.5 or 5 
minutes) of ischemia and reperfusion before 15 
minutes of left anterior descending artery occlusion 
and 2 hours of reperfusion were not associated with 
greater recovery of regional contractility. 4° Brief 
ischemia (5 to 10 minutes) or low-flow ischemia, 
before cardioplegic arrest at 34 ° C, did not improve 
left ventricular developed pressure in isolated per- 
fused rabbit hearts. 41 Gall and colleagues 47demon- 
strated that although repetitive coronary artery oc- 
clusion does not result in cumulative ischemic 
dysfunction, prior ischemic events ignificantly alter 
recovery of postischemic reperfusion. In the latter 
study, repetitive regional left anterior descending 
artery occlusion and reperfusion delayed recovery of 
myocardial creep but not recovery of systolic func- 
tion. Bolli and associates 48demonstrated that better 
regional contractility, as measured by recovery of 
wall thickening, was associated with a few episodes 
of left anterior descending artery occlusion but did 
not continue after 10 occlusions. In the present 
study, lack of cumulative l ft ventricular dysfunction 
and ventricular fibrillation after brief ischemia (10 
minutes) suggests that the myocardium became 
tolerant to additional repetitive global ischemia 
(preconditioning). Therefore one should not antici- 
pate greater ecovery of function or attenuation of 
myocardial stunning after the first episode of isch- 
emia, but the beneficial effects of brief ischemia nd 
reperfusion are expressed by the limitation of fur- 
ther deterioration of left ventricular function with 
additional episodes of ischemia (preconditioning). 
In the present study, nucleoside trapping acceler- 
ated functional recovery of the stunned myocardium 
when dogs were treated with EHNA/NBMPR. This 
drug intervention has been shown to attenuate 
reperfusion-mediated injury by preventing enera- 
tion of purine-mediated free radical production and 
subsequent vascular stunning. Failure to achieve a 
greater ecovery of function 4°-46 could be related to 
persistent vascular damage as a result of injury sus- 
tained by the heart during brief ischemia nd reperfu- 
sion. Stahl, Aversano, and Becker 49 demonstrated that 
selective enhancement of function of the stunned 
myocardium was observed by increasing coronary flow. 
In that study, one would expect hat augmentation f
contractility would be abolished when the coronary 
flow returned to the level of that in the stunned heart. 
Therefore greater ecovery of left ventricular perfor- 
mance in the EHNA/NBMPR group, in the present 
study, may be related to attenuation of reperfusion 
injury-mediated vascular injury in addition to that 
induced by ischemic preconditioning. 
Chen and associates 5° reported hemodynamic re- 
covery after four 15-minute pisodes of intermittent 
crossclamping in the presence or absence of lidofla- 
zine in dogs. The mechanisms by which lidoflazine, 
as a nucleoside transport inhibitor, allowed contin- 
uous release of adenosine is not known. Myocardial 
protection by lidoflazine was attributed to endoge- 
nous adenosine cardioprotective effects. Results 
from the same laboratory have demonstrated failure 
of R75231, a more selective inhibitor than lidofla- 
zine, to improve ventricular function, despite signif- 
icant accumulation of endogenous adenosine after 
four 15-minute episodes of intermittent ischemia 
and reperfusion. 51
Selective blockade of nucleoside transport by 
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NBMPR and EHNA attenuated myocardial stun- 
ning after a short period of reperfusion. 1s-21' 36-38 
The mechanisms of cardioprotective action of 
EHNA/NBMPR are believed to be related to site- 
specific entrapment of nucleosides. ATP repletion 
after 30 minutes of global ischemia and reperfu- 
sion ~s suggests that EHNA/NBMPR-trapped 
nucleosides are most likely to be compartmentalized 
inside cells. Indeed, Walsh and colleagues 52demon- 
strated that EHNA/NBMPR significantly reduced 
adenosine release from anoxic rabbit hearts, sug- 
gesting that adenosine is trapped in an intracellular 
compartment. Preservation of ATP seems to play a 
major role in myocardial preconditioning, asprevi- 
ously proposed. 9-11'3s The mechanism by which 
ATP is spared, although crucial, is not known. Other 
cardioprotective mechanisms of preconditioning 
have been investigated, including A s and A 3 recep- 
tor activation, KATe channels, and heat-shock pro- 
reins, ls-17 
Whether enhanced ventricular functional recov- 
ery, after documented myocardial stunning by pre- 
treatment with EHNA/NBMPR, is related to en- 
trapment of endogenous adenosine isnot clear from 
the present study. However, it is well established 
that adenosine limits the infarct size after prolonged 
ischemia and reperfusion 3° in a manner similar to 
that induced by ischemic preconditioning. Adeno- 
sine also activates A 1 receptor and NAT P channels. 
Although infusion of exogenous adenosine can 
mimic ischemic preconditioning, it failed to increase 
myocardial tolerance in terms of improvement of 
left ventricular developed pressure in isolated per- 
fused rat hearts. 53 Therefore the definition of isch- 
emic preconditioning may need to be broadened to 
include adaptive responses (memory) induced by 
prior stressfial experiences such as heat shock, beta 
receptor stimulation, anoxia, alcohol, aspirin, and 
anesthesia. It is plausible that lack of cumulative 
stunning is evidence of myocardial preconditioning. 
It is concluded that one brief episode of 10 
minutes of normothermic global ischemia and 
reperfusion caused myocardial stunning but aug- 
mented myocardial tolerance (that is, preventing 
cumulative stunning) when hearts were subjected to 
five subsequent episodes of ischemia and reperfu- 
sion. Selective nucleoside trapping may play a cru- 
cial role in :myocardial protection against reperfu- 
sion-mediated injury and arrhythmias in these 
models of global ischemia and reperfusion. An 
understanding of the mechanisms by which ATP is 
spared during subsequent episodes of ischemia is 
important and deserves further investigation. 
REFERENCES 
1. Lichtenstein SV, Ashe KA, EL Dalati H, Cusimano 
RJ, Panos A, Stutsky AS. Warm heart surgery. 
J THOP, AC CARDIOVASC SURG 1991;101:269-74. 
2. Bonchek LI, Burlingame MW, Vazales BE, Lundy 
EF, Gassmann CJ. Applicability of noncardioplegic 
coronary bypass to high-risk patients: selection of 
patients, technique, and clinical experience in 3000 
patients. J THOP, AC CARDIOVASC SURG 1992;103:230-7. 
3. Braimbridge M. Discussion of coronary bypass 
with substrate enhanced cardioplegia versus non- 
cardioplegic technique for early revascularization i  
acute infarction. Eur J Cardiothorac Surg 1991;4:124-9. 
4. Hendricks GR, Millard RW, McRitchie RJ, Maroko 
PR, Vatner SF. Regional myocardial functional and 
electrophysiological alterations after brief coronary 
occlusion in conscious dogs. J Clin Invest 1975;56:978- 
85. 
5. Weiner JM, Apstein CS, Arthur JH, Pirada FA, Hood 
WB Jr. Persistence of myocardial injury following 
brief periods of coronary artery occlusion. Cardiovasc 
Res 1976;10:678-86. 
6. Brunwald E, Kloner RA. The stunned myocardium: 
prolonged postischemic ventricular dysfunction. Cir- 
culation 1982;66:1146-9. 
7. DeBoer LWV, Ingwall JS, Kloner RA, Braunwald E. 
Prolonged erangement of canine myocardial purine 
metabolism after a brief coronary artery occlusion ot 
associated with anatomic evidence of necrosis. Proc 
Natl Acad Sci U S A 1980;77:5471-4. 
8. Triana JF, Li XY, Jamaluddin U, Thornby JI, Bolli R. 
Postischemic myocardial "stunning": identification of 
major differences between the open-chest and the con- 
scious dog and evaluation of the oxygen radical hypoth- 
esis in the conscious dog. Circ Res 1991;69:731-47. 
9. Swain JL, Sabina RL, Greenfield JC Jr, Holmes EW. 
Repetitive pisodes of brief ischemia (12 rain) do not 
produce a cumulative depletion of high energy phos- 
phate compounds. Cardiovasc Res 1984;18:264-9. 
10. Reimer KA, Murry CE, Yamasawa I, Hill ML, Jen- 
nings RB. Four brief episodes of myocardial ischemia 
cause no accumulative ATP loss or necrosis. Am J 
Physiol 1986;251:H1306-15. 
11. Murry C, Jennings R, Reimer K. Preconditioning with 
ischemia: a delay in lethal cell injury in ischemic 
myocardium. Circulation 1986;74:1124-36. 
12. Liu GS, Thornton J, Van Winkle DM, Stanley AWH, 
Olsson RA, Downey J. Protection against infarction 
afforded by preconditioning is mediated by Al-adcno- 
sine receptors in rabbit heart. Circnlation 1991;84:350-6. 
13. Abd-Elfattah AS, Ding M, Wechsler AS. Myocardial 
stunning and preconditioning: age-, species-, and 
3 3 8 Abd-Elfattah, Ding, Wechsler 
The Journal of Thoracic and 
Cardiovascular Surgery 
August 1995 
model-related differences in myocardial injury and 
protection. J Cardiac Surg 1993;5:311-7. 
14. Bolli R. Oxygen-derived free radicals and myocardial 
reperfusion injury: an overview. Cardiovasc Drugs 
Ther 1991;5(suppl 2):249-68. 
15. Krause SM. Effect of global myocardial stunning on 
Ca2(+)-sensitive myofibrillar ATPase activity and 
creatine kinase kinetics. Am J Physiol 1990;259(3 Pt 
2):H813-9. 
16. Gross GJ, Auchampach JA. Blockade of ATP-sensi- 
tive potassium channels prevents myocardial precon- 
ditioning in dogs. Circ Res 1992;70:223-33. 
17. Yellon DM, Latchman DS. Stress proteins and myo- 
cardial protection. J Mol Cell Cardiol 1992;24:113-24. 
18. Abd-Elfattah AS, Jessen ME, Lekven J, Doherty NE 
III, Brunsting LA, Wechsler AS. Myocardial reperfu- 
sion injury: role of myocardial hypoxanthine and 
xanthine on "free-radical-mediated" reperfusion i - 
jury. Circulation 1988;78(Suppl):III224-35. 
19. Abd-Elfattah AS, Jessen ME, Hanan SA, Tuchy G, 
Wechsler AS. Is adenosine-5'-triphosphate derange- 
ment or free-radical-mediated injury the major cause 
of ventricular dysfunction during reperfusion: role of 
adenine nucleoside transport in myocardial reperfu- 
sion injury. Circulation 1990;82(Suppl):IV341-50. 
20. Abd-Elfattah AS, Wechsler AS. Protection of the 
stunned myocardium: selective nucleoside transport 
blocker administered after 20 minutes of ischemia 
augments recovery of ventricular function. Circula- 
tion 1993;88(Suppl):II336-43. 
21. Abd-Elfattah AS, Jessen ME, Wechsler AS. Nucleo- 
side trapping during reperfusion prevents ventricular 
dysfunction, "stunning," in absence of adenosine: 
possible separation between ischemic and reperfusion 
injury. J THORAC CARDIOVASC SURG 1994;108:269-78. 
22. Kloner RA, Allen J, Cox TA, Zheng Y, Ruiz CE. 
Stunned left ventricular myocardium after exercise 
treadmill testing in coronary artery disease. Am J 
Cardiol 1991;68:329-34. 
23. Pfisterer M, Zuber M, Wenzel R, Burkart F. Pro- 
longed myocardial stunning after thrombolysis: can 
left ventricular function be assessed efinitely at hos- 
pital discharge? Eur Heart J 1991;12:214-7. 
24. Renkin J, Wijns W, Ladha Z, Col J. Reversal of 
segmental hypokinesis by coronary angioplasty in 
patients with unstable angina, persistent T wave in- 
version, and left anterior descending artery stenosis: 
additional evidence for myocardial stunning in hu- 
mans. Circulation 1990;82:913-21. 
25. Glower DD, Spratt JA, Snow ND, et al. Linearity of 
the Frank-Starling relationship nthe intact heart: the 
concept of preload recruitable stroke work. Circula- 
tion 1985;71:994-1009. 
26. Morris JJ III, Pellom GL, Murphy CE, Salter DR, 
Goldstein JG, Wechsler AS. Quantification of the 
contractile response: assessment of the work-length 
relationship in the intact heart. Circulation 1987;76: 
717-27. 
27. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 
Protein measurement with Folin phenol reagent. 
J Biol Chem 1951;193:265-75. 
28. Hull-Ryde EA, Lewis WR, Veronne CD, Lowe JE. 
Simple step gradient elution of the major high-energy 
compounds and their catabolites in cardiac muscle 
using high performance liquid chromatography. 
J Chromatogr B Biomed Appl 1986;377:165-74. 
29. Abd-Elfattah AS, Wechsler AS. Superiority of HPLC 
to assay for enzymes regulating adenine nucleotidase 
pool intermediates metabolism: 5'-nucleotidase, ad- 
enylate deaminase, adenosine deaminase and adeny- 
losuccinate lyase--a simple and rapid determination 
of adenosine. J Liquid Chromatogr 1987;10:2653-94. 
30. Thornton JD, Liu GS, Olsson RA, Downey JM. 
Intravenous pretreatment of Al-selective adenosine 
analogues protects the heart against infarction. Circu- 
lation 1992;85:659-65. 
31. Ytrehus K, Liu Y, Downey JM. Preconditioning pro- 
tects the ischemic rabbit heart by protein kinase C 
activation. Am J Physiol 1994;266:Hl145-52. 
32. Gross GJ, Yao Z, Auchampach JA. KAW p channels, 
adenosine r ceptors and ischemic preconditioning. In:
Abd-Elfattah ASA, Wechsler AS, eds. Purines and 
myocardial protection. Boston: Kluwer Academic 
Publishers. (In press). 
33. Marber MS, Walker JM, Latchman DS, Yellon DM. 
Myocardial protection after whole body heat stress in 
the rabbit is dependent on metabolic substrate and is 
related to the amount of the inducible 70-KD heat 
stress protein. J Clin Invest 1994;93:1087-94. 
34. Warner KG, Khuri SF, Deupree RH, et al. Signifi- 
cance of transmural diminution in regional hydrogen 
ion production after repeated coronary artery occlu- 
sions. Circ Res 1989;64:616-29. 
35. Van der Heide RS, Reimer KA, Jennings RB. Intra- 
coronary infusion of adenosine slows the rate of 
ischemic myocardial metabolism ina model of total in 
vitro ischemia: relationship to ischemic precondition- 
ing. Cardiovasc Res 1993;27:669-73. 
36. Abd-Elfattah AS, Ding M, Dyke CM, Dignan R, 
Wechsler AS. Attenuation of ventricular dysfunction 
"stunning" following normothermic ischemia nd hy- 
pothermic ardioplegic arrest by augmentation of 
endogenous adenine nueleosides [Abstract]. Circula- 
tion 1992;86(Suppl):I103. 
37. Zuoghaib ME, Abd-Elfattah AS, Jeroudi MO, et al. 
Augmentation of endogenous adenosine attenuates 
myocardial "stunning" independently of coronary 
flow or hemodynamic effects. Circulation 1993;88[part 
1]:2359-69. 
38. Abd-Elfattah AS, Wechsler AS. Separation between 
ischemic and reperfusion i jury by site specific entrap- 
ment of endogenous adenosine and inosine using 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 110, Number 2 
Abd-Elfattah, Dins, Wechsler 3 3 9 
NBMPR and EHNA. J Cardiac Surg 1994;9(Suppl): 
387-96. 
39. Gao WD, Atar D, Backx PH, Marban E. Direct 
measurements of Ca 2+ responsiveness of the contrac- 
tile proteins in intact stunned myocardium [Abstract]. 
Circulation 1994;90(part 4):I646. 
40. Ovize M, Przyklenk K, Hale SL, Kloner RA. Precon- 
ditioning does not attenuate myocardial stunning. 
Circulation 1992;85:2247-54. 
41. Bolling SF, Olzanski DC, Child KF, Gallagher KP. 
Does cardiac "preconditioning" result in enhanced 
postischemic functional recovery? Surg Forum 1991; 
42:239-42. 
42. Miura T, Goto M, Urbe K, Endoh A, Shimamoto K, 
Iimura O. Does myocardial stunning contribute to 
infarct size limitation by ischemic preconditioning? 
Circulation 1991;84:2504-12. 
43. Li YW, Whittaker P, Kloner RA. The transient nature 
of the effect of ischemic preconditioning on myocar- 
dial infarct size and ventricular arrhythmia. Am Heart 
J 1992;12.3:246-53. 
44. Liu GS, Thornton J, Van Winkle DM, Stanley AW, 
Olsson RA, Downey JM. Protection against infarction 
afforded by preconditioning is mediated by A1 adeno- 
sine receptors inrabbit heart. Circulation 1991;84:350-6. 
45. Ellis SG, Wynne J, Braunwald E, Henschke CI, 
Sandor T, Kloner RA. Response of reperfusion- 
salvaged, stunned myoeardium to inotropic stimula- 
tion. Am Heart J 1984;107:13-9. 
46. Matsuda M, Catena TG, Vander Heide RS, Jeunings 
RB, Reimer KA. Cardiac protection by ischaemic 
preconditioning is not mediated by myocardial stun- 
ning. Cardiovasc Res 1993;27:585-92. 
47. Gall SA Jr, Maier GW, Gayron JW, Feneley MP, 
Rankin JS, Glower DD. Mechanism of delayed myo- 
cardial recovery after repetitive ischemic episodes. 
Surg Forum 1991;42:243-5. 
48. Bolli R, Zuyghaib M, Li XY, et al. Stunning after 
repetitive ischemia is caused by recurrent bursts of 
free radical production without a preconditioning 
effect [Abstract]. Circulation 1993;88(part 2):I130. 
49. Stahl LD, Aversano TR, Becker LC. Selective n- 
hancement of function of stunned myocardium by 
increased coronary flow. Circulation 1986;74:843-51. 
50. Chen CC, Masuda M, Szabo Z, et al. Nucleoside 
transport inhibitor lidoflazine induced cardioprotec- 
tion during intermittent aortic cross-clamping. J THO- 
RAC CARDIOVASC SURG 1992;104:1602-9. 
51. Flameng W, Chen CC, Mubagwa K. Accumulation of 
endogenous adenosine by nucleoside transport inhi- 
bition failed to protect the ischemic myocardium 
[Abstract]. J Mol Cell Cardiol 1992;24(Suppl II): 
$14. 
52. Walsh R, Abd-Elfattah AS, Daly JJF, Wechsler AS, 
Downey JM. Nucleoside transport inhibition prevents 
ischemic preconditioning [Abstract]. Circulation 1993; 
88(part 2):I432. 
53. Hendrikx M, Toshima Y, Mubagwa K, Flameng W. 
Improved functional recovery after ischemic precon- 
ditioning in the globally ischemic rabbit heart is not 
mediated by adenosine Al-receptor activation [Ab- 
stract]. Circulation 1992;86(Suppl):I342. 
1-800-55-MOSBY 
This number links you to the full text of articles published in over 25,000 journals, including all Mosby journals. MOSBYDoeument 
Express ®, a rapid response information retrieval service, provides quick turnaround, 24-hour availability, and speedy delivery 
methods. For inquiries and pricing information, call our toll-free, 24-hour order line: 1-800-55-MOSBY; outside the United States: 
415-259-5046; fax: 415-259-5019; E-mail: mosbyexp@class.org. 
MOSBY Document Express ~is offered in cooperation with Dynamic Information Corp. 
